NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $167,900 | +1.4% | 1,825 | 0.0% | 0.11% | -0.9% |
| Q4 2022 | $165,564 | +19.1% | 1,825 | 0.0% | 0.11% | +4.8% |
| Q3 2022 | $139,000 | -9.7% | 1,825 | 0.0% | 0.10% | -6.3% |
| Q2 2022 | $154,000 | -3.8% | 1,825 | 0.0% | 0.11% | +11.0% |
| Q1 2022 | $160,000 | 0.0% | 1,825 | 0.0% | 0.10% | +3.1% |
| Q4 2021 | $160,000 | -19.2% | 1,825 | -24.4% | 0.10% | -25.4% |
| Q3 2021 | $198,000 | -10.0% | 2,413 | 0.0% | 0.13% | -10.3% |
| Q2 2021 | $220,000 | -84.8% | 2,413 | -85.8% | 0.14% | -86.4% |
| Q1 2021 | $1,452,000 | -10.0% | 16,988 | -0.5% | 1.07% | -10.9% |
| Q4 2020 | $1,613,000 | +11.9% | 17,079 | +3.1% | 1.20% | +0.1% |
| Q3 2020 | $1,441,000 | -3.8% | 16,570 | -3.9% | 1.20% | -11.1% |
| Q2 2020 | $1,498,000 | +62.6% | 17,239 | +54.3% | 1.34% | +57.5% |
| Q1 2020 | $921,000 | -7.7% | 11,170 | +5.9% | 0.85% | -7.5% |
| Q4 2019 | $998,000 | – | 10,544 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |